n-acetylneuraminic acid and Benign Monoclonal Gammopathies

n-acetylneuraminic acid has been researched along with Benign Monoclonal Gammopathies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fleming, SC; Knowles, D; Self, CH; Skillen, A; Smith, S1

Other Studies

1 other study(ies) available for n-acetylneuraminic acid and Benign Monoclonal Gammopathies

ArticleYear
Increased sialylation of oligosaccharides on IgG paraproteins--a potential new tumour marker in multiple myeloma.
    Journal of clinical pathology, 1998, Volume: 51, Issue:11

    Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Diagnosis, Differential; Female; Humans; Immunoglobulin G; Male; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; N-Acetylneuraminic Acid; Neoplasm Proteins; Neoplasm Staging; Oligosaccharides; Paraproteins

1998